Ethnic pharmacological relevance Pulmonary fibrosis (PF) is a fibrotic interstitial lung
disease caused by continuous damage and excessive repair of alveolar epithelial cells, the …

Pulmonary fibrosis is a chronic progressive interstitial lung disease caused by a variety of
etiologies. The disease can eventually lead to irreversible damage to the lung tissue …

Ethnopharmacological relevance Pulmonary fibrosis (PF) is a chronic, debilitating and often
lethal lung disorder. Despite the molecular mechanisms of PF are gradually clear with …

Objective• To summarize the use of Chinese Herbal Medicines (CHMs) for Idiopathic
Pulmonary Fibrosis (IPF) and provide high-level evidence for clinical decisions. Methods• …

Objective. To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung
function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta‐analysis …

Background and objective: Idiopathic pulmonary fibrosis (IPF) is a critical disease, with
limited treatments available. Clinical practices show that traditional Chinese medicine (TCM) …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung scarring condition with
the histological characteristic of typical interstitial pneumonia. Injury to alveolar epithelial …

Pulmonary fibrosis (PF) is a chronic and irreversible pulmonary disease, and can lead to
decreased lung function, respiratory failure and even death. The pathogenesis research and …

Background: Since December 2019, there have been many cases of viral pneumonia of
unknown causes in Wuhan City, Hubei Province. During the period of novel coronavirus …

Pulmonary fibrosis (PF) is a highly confounding and fatal pathological process with finite
treatment options. Multiple factors such as oxidative and immune/inflammation involve key …